FDA.reportPublic FDA data

raltegravir 100 MG Granules for Oral Suspension

RxCUI
1486838
RxNorm name
raltegravir 100 MG Granules for Oral Suspension
Display name
raltegravir 100 MG Granules for Oral Suspension
Full name
raltegravir 100 MG Granules for Oral Suspension
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
89a5ec53-d956-4329-8004-0f40f51c88a3raltegravir 100 MG Granules for Oral Suspension [PSN] · raltegravir 100 MG Granules for Oral Suspension [SCD] · raltegravir 100 MG (as raltegravir potassium 108.8 MG) Granules for Oral Suspension [SY]370These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) film-coated tablets, for oral use ISENTRESS ® HD (raltegravir) film-coated tablets, for oral use ISENTRESS ® (raltegravir) chewable tablets, for oral use ISENTRESS ® (raltegravir) for oral suspension Initial U.S. Approval: 200720241018